# A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis

> clinical trial · VERIFIED · 2026-06-23

Status: ACTIVE_NOT_RECRUITING · Sponsor: Hoffmann-La Roche · Condition: Multiple Sclerosis, Primary Progressive

- Company: Hoffmann-La Roche
- Sector: neurology
- Primary source: https://clinicaltrials.gov/study/NCT04544449

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.